Tyrosine Kinases in Autoimmunity
自身免疫中的酪氨酸激酶
基本信息
- 批准号:7197330
- 负责人:
- 金额:$ 25.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-09 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:ActinsAddressAllergicAnimal ModelAnimalsAnti-Inflammatory AgentsAnti-inflammatoryAntibody FormationAutoimmune DiseasesAutoimmune ProcessAutoimmunityCytoskeletonDataEventExperimental ModelsExtrinsic asthmaGuanine Nucleotide Exchange FactorsHypersensitivityImmune System DiseasesImmune systemInflammatoryJurkat CellsLaboratoriesLungMediatingMonomeric GTP-Binding ProteinsMusNucleotidesPathologyPathway interactionsPatientsPhenotypePhosphorylationPhosphotransferasesPlayProductionProtein Tyrosine KinaseProteinsRegulationRoleSignal PathwaySignal TransductionSignal Transduction PathwaySystemSystemic Lupus ErythematosusT-Cell DevelopmentT-Cell ProliferationT-Cell ReceptorT-LymphocyteTestingTranscriptional ActivationTransgenesTransgenic AnimalsTransgenic MiceTyrosine PhosphorylationVirus Diseasescytokinehuman diseasein vivointerestmutantpathogenpolymerizationreconstitutionresponsetransgene expressionvasodilator-stimulated phosphoprotein
项目摘要
DESCRIPTION (provided by applicant): Immunological diseases where the immune system responds inappropriately, such as some allergic and autoimmune disorders, display aberrant T cell antigen receptor (TCR/CD3)-induced signaling events. These may include intracellular Ca++ mobilization and the reorganization of the actin cytoskeleton. The protein tyrosine kinase Itk is a critical regulator of these events. Therefore, we believe studies on Itk are important to our understanding of such immunological diseases. We propose the hypothesis that Itk regulates important TCR/CD3-induced signal transduction events including intracellular Ca++ mobilization and reorganization of the actin cytoskeleton. Furthermore, we propose that Itk regulates these events through its various structural domains. In view of this hypothesis the present proposal will address the following three specific aims:
1) Structural requirements of Itk on T cell development and activation. We will reconstitute Itk-deficient mice with selected mutant Itk transgenes that have been shown to display interesting phenotypes. Reconstituted mice will be tested for effects on T cell development, activation, transcriptional activation and cytokine production, TCR-proximal signaling events, and in vivo responses to viral infection. 2) Structural requirements of Itk on the modulation of allergic asthma. For these studies we will utilize the Itk transgenic mice of specific aim 1. Reconstituted mice will be challenged in an experimental model of allergic asthma and the effects of various Itk transgene expression on lung pathology, T cell proliferation, and cytokine production will be determined. 3) Involvement of Itk in TCR/CD3-induced cytoskeletal events. We will assess the involvement of Itk on TCR/CD3-induced actin polymerization, the inducible interaction of Itk with WASP, the interaction of WASP with other actin-polymerization related proteins (e.g. VASP and Arp2/3), and the Ilk structural requirements for these interactions, the role of the Itk-mediated phosphorylation of WASP on actin polymerization, and the involvement of Itk in TCR/CD3-mediated activation of small GTPases and the nucleotide exchange factor Vav.
描述(由申请人提供):免疫系统反应不当的免疫疾病,例如一些过敏性和自身免疫性疾病,表现出异常的 T 细胞抗原受体 (TCR/CD3) 诱导的信号事件。这些可能包括细胞内 Ca++ 动员和肌动蛋白细胞骨架的重组。蛋白酪氨酸激酶 Itk 是这些事件的关键调节因子。因此,我们相信对 Itk 的研究对于我们了解此类免疫疾病非常重要。我们提出这样的假设:Itk 调节重要的 TCR/CD3 诱导的信号转导事件,包括细胞内 Ca++ 动员和肌动蛋白细胞骨架的重组。此外,我们建议 Itk 通过其各种结构域来调节这些事件。鉴于这一假设,本提案将解决以下三个具体目标:
1) Itk对T细胞发育和激活的结构要求。我们将用选定的突变型 Itk 转基因重建 Itk 缺陷小鼠,这些突变型 Itk 转基因已被证明表现出有趣的表型。将测试重组小鼠对 T 细胞发育、激活、转录激活和细胞因子产生、TCR 近端信号传导事件以及对病毒感染的体内反应的影响。 2) Itk对调节过敏性哮喘的结构要求。对于这些研究,我们将利用特定目标 1 的 Itk 转基因小鼠。将在过敏性哮喘实验模型中挑战重组小鼠,并确定各种 Itk 转基因表达对肺病理学、T 细胞增殖和细胞因子产生的影响。 3) Itk 参与 TCR/CD3 诱导的细胞骨架事件。我们将评估 Itk 对 TCR/CD3 诱导的肌动蛋白聚合的参与,Itk 与 WASP 的诱导相互作用,WASP 与其他肌动蛋白聚合相关蛋白(例如 VASP 和 Arp2/3)的相互作用,以及这些相互作用的 Ilk 结构要求,Itk 介导的 WASP 磷酸化对肌动蛋白聚合的作用,以及 Itk 的参与 TCR/CD3 介导的小 GTP 酶和核苷酸交换因子 Vav 的激活。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CONSTANTINE D TSOUKAS其他文献
CONSTANTINE D TSOUKAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CONSTANTINE D TSOUKAS', 18)}}的其他基金
ANALYSIS OF EPSTEIN BARR/VIRUS C3D RECEPTORS IN T LYMPHOCYTES
T 淋巴细胞中 Epstein Barr/病毒 C3D 受体的分析
- 批准号:
6576901 - 财政年份:2002
- 资助金额:
$ 25.2万 - 项目类别:
ANALYSIS OF EPSTEIN BARR/VIRUS C3D RECEPTORS IN T LYMPHOCYTES
T 淋巴细胞中 Epstein Barr/病毒 C3D 受体的分析
- 批准号:
6435878 - 财政年份:2001
- 资助金额:
$ 25.2万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 25.2万 - 项目类别:
Research Grant